CMS 2027 Final Rule Preview: Wound Care's Key Watch Items

Every year wound care practices brace for November—the month CMS drops its final rules and locks in what you'll actually get paid for the next 12 months. The CMS 2027 Final Rule (both the Physician Fee Schedule and the Outpatient Prospective Payment System) is expected in early November 2026. With the proposed rules already published, the broad strokes are clear. Now is the time to stress-test your revenue model before the numbers become final.

This post walks through the highest-stakes provisions from the proposed rules, what to watch for when the final rules publish, and the steps to take before January 1, 2027.

Why the 2027 Final Rule Matters More Than Usual for Wound Care

Three converging pressures make this cycle unusually high stakes:

1. Skin substitute flat-rate pressure. The 2026 move to a single $127.14/sq cm flat rate for skin substitutes under OPPS reshaped practice economics overnight. The 2027 proposed rule signals further APC restructuring—specifically around consolidation of high-cost biologics into lower-weight APCs.
2. Conversion factor compression. The PFS conversion factor has declined or held flat for five consecutive years. CMS has proposed a 2027 conversion factor that, before budget neutrality adjustments, results in further downward pressure on procedure-heavy specialties including wound care.
3. LCD alignment deadlines. Several MAC jurisdictions have issued final LCDs with compliance effective dates in Q1 2027. The final PFS rule can accelerate or modify those timelines when it references coverage criteria.

If your practice revenue depends on a mix of debridement CPT codes, skin substitute applications, and evaluation and management visits, all three tracks deserve attention.

Skin Substitute Reimbursement: What the Proposed OPPS Rule Signals

The CMS 2027 OPPS proposed rule continues the trajectory started in 2026 by maintaining the flat-rate methodology but proposing two new APC tiers for products that exceed a cost-to-charge threshold. Under the proposal:

• Products with a reported cost per square centimeter above a CMS-defined threshold would be carved into a separate high-cost APC rather than reimbursed at the flat rate.
• Products at or below the threshold would remain in the consolidated flat-rate pool.
• Hospitals and provider-based wound care departments would bear the risk of product selection relative to the applicable APC assignment.

For non-facility (office and home) settings, the PFS proposed rule does not change the facility/non-facility split for skin substitute applications but does propose revising the work RVUs for CPT 15271 and its add-on codes based on updated time and intensity surveys.

What to watch in the final rule: Whether CMS finalizes the two-tier APC structure or collapses it back to a single flat rate. Comments from industry stakeholders—including SAWC and APWCA—pushed back on the tiered approach as adding administrative burden without clinical rationale. The final rule will reflect CMS's response to those comments.

For a deeper breakdown of how the current OPPS changes affect your billings, see our guide on skin substitute billing.

Debridement CPT Codes: RVU Changes on the Table

The PFS proposed rule includes updated Relative Value Unit (RVU) surveys across several wound care procedure codes. The most significant proposed changes:

CPT 97597 and 97598 (Selective Debridement)

CMS proposed adjusting practice expense RVUs for 97597 and 97598 based on new supply cost inputs. The proposed changes reflect lower supply cost assumptions—which, if finalized, reduce the non-facility payment rate. Practices performing selective debridement in home or office settings would see a modest rate decrease.

CPT 11042-11047 (Excisional Debridement Series)

Work RVUs for the 11042-11047 family remain relatively stable in the proposed rule. However, CMS is evaluating whether the time estimates in the current RVU database still accurately reflect current practice. If surveys indicate faster procedure times, work RVU reductions are possible in the final rule.

E/M Visit Codes Billed on the Same Day

The proposed rule does not change modifier 25 guidance for same-day wound care evaluation and management visits, but CMS has signaled renewed scrutiny of same-day E/M and procedure billing as part of its broader program integrity focus. Ensure your documentation clearly supports the separately identifiable E/M when billing on the same day as a procedure.

For the full CPT code landscape, our wound care CPT codes guide remains the reference for 2026 base rates to compare against proposed 2027 figures.

OPPS 2027: Provider-Based Wound Care Departments

If you operate or are considering a provider-based wound care department, the 2027 OPPS proposed rule includes several provisions directly relevant to your cost-reporting and billing structure:

• New packaged service rules may extend the list of supplies considered "packaged" into the APC payment, reducing separately billable HCPCS codes.
• Site-neutral payment expansion proposals are present again in 2027. CMS continues to narrow the payment differential between hospital outpatient departments (HOPDs) and free-standing settings for certain services. Wound care is not yet a target for full site-neutral payment, but the trend line matters for long-range planning.
• 340B drug pricing adjustments may affect how provider-based departments that participate in 340B account for skin substitute products under cost reporting—a secondary but real revenue impact.

Our detailed analysis of the proposed OPPS changes is in the 2027 OPPS proposed rule breakdown.

LCD Compliance Deadlines Coinciding With the Final Rule Window

A complicating factor in 2027 planning: several MAC LCDs with wound care implications have effective dates in January 2027. The final PFS rule can interact with these LCDs when CMS includes coverage language or references NCD authority.

Practices that haven't completed a documentation gap analysis against their applicable MAC LCD should do so before November. When the final rule publishes, you'll have six weeks before the effective date—not enough time to rebuild documentation workflows from scratch.

The key LCD compliance areas to audit now:

• Clinical indication documentation for skin substitute applications (frequency, wound measurements, prior conservative care evidence)
• Debridement necessity documentation when multiple codes are billed on the same date
• Wound photography and measurement documentation standards referenced in your MAC's LCD

Our wound care LCD compliance guide covers the documentation standards that apply across MAC jurisdictions.

Revenue Model Stress-Testing Before January 1

The window between the final rule publication (expected early November) and the effective date (January 1, 2027) is tight. Practices that run the numbers before November can adapt faster.

A basic stress-test approach:

1. Pull your 2026 YTD procedure volume by CPT code.
2. Apply the proposed rate changes from the PFS and OPPS proposed rules.
3. Identify your top three highest-revenue codes and model the impact of a 3%, 5%, and 8% rate reduction on each.
4. Compare the modeled revenue to your fixed cost baseline—staffing, supplies, and overhead per visit.

If the 3% scenario still covers your cost per visit with acceptable margin, you can absorb most final rule outcomes without operational changes. If the 5% scenario puts you below break-even on skin substitute cases, you need a product selection and mix strategy ready before January.

The revenue model framework in our wound care practice revenue model guide provides the per-visit cost structure to plug proposed rate changes into.

What to Do When the Final Rule Publishes

When CMS publishes the 2027 PFS and OPPS Final Rules (watch the Federal Register, typically the first week of November):

1. Verify the conversion factor. The final conversion factor is the single multiplier that cascades through every work + PE + MP RVU calculation. Confirm the finalized number against the proposed.
2. Pull the addenda. CMS publishes Addendum B (PFS payment rates by code) and the OPPS Addendum B (APC rates) with the final rule. These are the operational rate tables.
3. Check skin substitute APC assignments. The final rule will list any product-level APC reassignments.
4. Update your fee schedule. Your billing system or billing service needs the new rates loaded before January 1. Build in a two-week buffer for QA.
5. Communicate with your billing team. If you outsource billing, confirm their update timeline. Payers also update their systems on January 1—claims submitted with stale fee schedule data are a denial risk on day one.

Running a pre-billing audit on your top CPT codes in December is standard practice for high-volume wound care providers.

Key Takeaways

• The CMS 2027 Final Rule is expected in early November 2026—plan to act on it within days of publication, not weeks.
• Skin substitute reimbursement remains under structural pressure; a two-tier APC proposal for high-cost products is the key provision to watch in the final OPPS rule.
• Debridement CPT codes (97597/97598) face modest practice expense RVU reductions under the proposed PFS; excisional debridement codes are more stable.
• MAC LCD compliance deadlines for January 2027 are not linked to the final rule timeline—documentation audits should begin now, not after November.
• A pre-January revenue model stress-test using proposed rates can identify which service lines need product mix or volume adjustments before the effective date.